About Valneva SE - ADR (VALN)
Valneva is a biotechnology company. The Company focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva serves customers in France.
- USD10.14
- USD10.15
- USD9.85
- 41.58k
Stock News
3 hours ago
Coinbase CEO says key crypto vote can be rescheduled after 11th hour cancellation
CNBC
yesterday
Taiwan Semiconductor's record quarter renewed investors' faith in AI stocks, Jim Cramer says
CNBC
yesterday
College sports has a new money problem — and St. John’s may be the latest example: ‘It’s the Wild West’
MarketWatch
yesterday
Trump pitches direct payments to consumers for health care. What policy experts say about the plan
CNBC